Clinical Trial Update: Immunoadsorption in Patients With Severe Systemic Sclerosis [NA]

View source ↗

Summary

The clinical trial update indicates that the immunoadsorption study in patients with severe systemic sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Systemic Scleroderma | NA | Status: TERMINATED